NCT01686256View on ClinicalTrials.gov

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2004

Conditions
Ovarian CancerEndometrial Cancer
Interventions
DRUG

Tc 99m EC20

Each subject will receive 1 mg of folic acid injected 1-3 minutes prior to administration of Technetium Tc 99m EC20.

Trial Locations (1)

Unknown

Indiana University Medical Center, Indianapolis

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01686256 - Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer | Biotech Hunter | Biotech Hunter